Please login to the form below
Maximising ROI from mature brands
News that Eli Lilly and Co has forecast a drop in 2014 profits and
reduced its sales outlook because of generic competition to its Cymbalta antidepressant
and Evista drug for osteoporosis, underlines the challenges
that pharma companies face when patents expire.
Read the full article here:
http://www.pmlive.com/digital_handbook/online_audiences/online_physician_communities/maximising_roi_from_mature_brands/
Read the full article here:
http://www.pmlive.com/digital_handbook/online_audiences/online_physician_communities/maximising_roi_from_mature_brands/
